Expert Review of Clinical Pharmacology

SJR Rank #6,328H-index: 73SJR: 0.848Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1
  • Medicine (miscellaneous)Q2
  • Pharmacology (medical)Q2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of LifePharmaceutical studies and practicesPharmacogenetics and Drug MetabolismPharmacological Effects and Toxicity StudiesPharmaceutical Practices and Patient OutcomesAntibiotics Pharmacokinetics and EfficacyAsthma and respiratory diseasesLipoproteins and Cardiovascular HealthRheumatoid Arthritis Research and Therapies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs090180270360

Documents per Year

2022202503570105140

Detailed Information

ISSN

1751-2433, 1751-2441

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.19

References per Document

71.96

Coverage

2008-2026

Scope

Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery. Clinical Pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.

Metrics from SCImago Journal Rank 2025. View on SCImago